A large-scale study, presented at UEG Week 2026, has identified distinct antibody patterns up to 10 years before the ...

Antibiotic use from childhood through early adulthood is associated with higher odds of irritable bowel syndrome (IBS) at age 24, with the odds increasing as the number of antibiotic prescriptions ...

Patients who smoke or vape cannabis may need more anesthesia during an upper endoscopy than those who use edibles or do not ...

Spyre Therapeutics presents clinical data for IBD therapies at UEGW 2026, highlighting combination treatment efficacy.

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete ...

United European Gastroenterology (UEG) has today launched its new Patient Representatives Advisory Board (PRAB), creating a dedicated platform to embed patient perspectives within its public affairs ...

The phase IIb ANTHEM-UC trial found that icotrokinra (Icotyde), an oral peptide that blocks the interleukin-23 (IL-23) ...